Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

Three doses of 50 mg/kg of body weight administered intravenously every third day beginning on Day 1

Administered intravenously with a loading dose on Day 1 (200 mg for adults and pediatric patients with body weight \>= 40 kg and for pediatric patients weighing \< 40 kg one loading dose of remdesivir 5 mg/kg) followed by 9 to 13 days of once-daily maintenance dosing starting on Day 2 and extending through Day 10 to 14 (100 mg for adults and pediatric patients with body weight \>= 40 kg and for pediatric patients weighing \< 40 kg remdesivir 2.5 mg/kg)

50 mg/kg of body weight administered intravenously on Day 1 as a single infusion

150 mg/kg of body weight administered intravenously on Day 1 as a single infusion